Douglas Labs Picks Up New Technology from SourceOne

PITTSBURGH—Douglas Laboratories developed a new coenzyme Q10 (CoQ10) dietary supplement for distribution via health care professionals that uses the VESIsorb® delivery system from SourceOne Global Partners. The new technology, a self-assembling association colloid delivery system, was developed by Vesifact, and launched by SourceOne. Douglas Labs is using the VESIsorb delivery system for its CoQ10 formula, Citrus Solu-Q™, which uses SourceOne’s CoQsource®. It is delivered in a novel, proprietary two-piece liquid-filled hard shell capsule, Caplique™, an exclusive from AquaCap.

“With the VESIsorb® delivery system, SourceOne can now offer bio-enhanced ingredients and proprietary formulas containing CoQ10 in either the ubiquinone or ubiquinol (QH) forms,” said Jesse Lopez, founder and CEO, SourceOne. “Perhaps even more compelling is our ability to deliver proprietary omega-3 and CoQ10 combinations as well as using VESIsorb to significantly improve the absorption of other natural lipophilic bio-actives.”